| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.35B | 15.77B | 17.18B | 18.63B | 20.70B | 25.39B |
| Gross Profit | 7.34B | 7.55B | 8.26B | 8.76B | 10.09B | 12.16B |
| EBITDA | -529.00M | -274.00M | 263.00M | 433.00M | 966.00M | 2.24B |
| Net Income | -349.00M | -164.00M | 217.00M | 657.00M | 751.00M | 1.54B |
Balance Sheet | ||||||
| Total Assets | 12.87B | 12.73B | 14.53B | 13.39B | 13.83B | 15.19B |
| Cash, Cash Equivalents and Short-Term Investments | 10.15B | 10.08B | 11.92B | 10.23B | 10.78B | 11.84B |
| Total Debt | 0.00 | 0.00 | 1.00M | 2.00M | 0.00 | 1.00M |
| Total Liabilities | 3.94B | 3.70B | 4.16B | 3.97B | 5.06B | 6.14B |
| Stockholders Equity | 8.81B | 8.90B | 10.30B | 9.39B | 8.73B | 9.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -576.00M | 687.00M | -614.00M | -101.00M | 2.43B |
| Operating Cash Flow | 0.00 | -573.00M | 691.00M | -613.00M | -101.00M | 2.43B |
| Investing Cash Flow | 0.00 | 158.00M | -16.00M | 101.00M | -541.00M | -55.00M |
| Financing Cash Flow | 0.00 | -1.37B | 582.00M | -151.00M | -1.18B | -182.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥5.27B | 16.04 | ― | 5.27% | 6.79% | -30.39% | |
73 Outperform | ¥10.43B | 15.63 | ― | ― | 7.76% | 12.44% | |
72 Outperform | ¥25.74B | 12.02 | ― | 2.01% | 6.10% | ― | |
70 Outperform | ¥6.48B | 13.28 | ― | 0.87% | -3.02% | -30.86% | |
68 Neutral | ¥4.12B | 29.83 | ― | 2.04% | 4.91% | -60.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
48 Neutral | ¥9.32B | 64.79 | ― | 1.02% | -8.03% | ― |